marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-10-2022
Viveve Medical Balance Sheet 2011-2024 | VIVE
Annual Balance Sheet Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | -6.52 M | -9.06 M | 1 M | 8.22 M | 1.54 M | -2.53 M | 1.6 M | 3.77 M | 7.84 M | 2.74 M |
Long Term Debt |
- | - | 3.98 M | 30.5 M | 28.9 M | 7.76 M | - | - | 4.54 M | 8.1 M | 5.33 M |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 498 K | 4.15 M | 31.2 M | 29.3 M | 7.82 M | - | - | 7.22 M | 11.9 M | 6.93 M |
Total Current Liabilities |
4.53 M | 4.22 M | 6.31 M | 10.8 M | 9.4 M | 7.14 M | - | 3.14 M | 983 K | 1.14 M | 710 K |
Total Liabilities |
10.8 M | 9.66 M | 10.5 M | 41.9 M | 38.7 M | 15 M | 7.56 M | 3.14 M | 8.2 M | 13 M | 7.64 M |
Deferred Revenue |
- | - | 770 K | 686 K | - | - | - | - | - | 317 K | 277 K |
Retained Earnings |
-242 M | - | -198 M | -155 M | -106 M | -68.6 M | -48.5 M | -36.1 M | -104 M | -107 M | -98.7 M |
Total Assets |
25.9 M | 16.6 M | 27 M | 46.8 M | 36.1 M | 14.5 M | 11.5 M | 2.3 M | 1.56 M | 1.09 M | 3.55 M |
Cash and Cash Equivalents |
19.2 M | 6.52 M | 13.3 M | 29.5 M | 20.7 M | 8.09 M | 7.36 M | 895 K | 430 K | 258 K | 2.58 M |
Book Value |
15.1 M | 6.97 M | 16.5 M | 4.91 M | -2.6 M | -405 K | 3.94 M | -841 K | -6.64 M | -11.9 M | -4.09 M |
Total Shareholders Equity |
15.1 M | 6.97 M | 16.5 M | 4.91 M | -2.6 M | -405 K | 3.94 M | -841 K | -7.31 M | -11.9 M | -4.09 M |
All numbers in USD currency
Quarterly Balance Sheet Viveve Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | 97 K | 425 K | 425 K | 425 K | 5.99 M | 5.99 M | 45.8 M | 46.5 M | 47.2 M | 47.9 M | 48.6 M | 49.2 M | 49.9 M | 50.5 M | 34.4 M | 34.8 M | - | - | - | - | 4.85 M | 5.21 M | 5.45 M | 4.36 M | 3.85 M | 2.77 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 11 M | 10.2 M | 10.5 M | 10.8 M | 10 M | 8.91 M | 10.1 M | 9.66 M | 9.66 M | 9.66 M | 9.66 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 41.9 M | 41.9 M | 41.9 M | 41.9 M | 38.7 M | 38.7 M | 38.7 M | 38.7 M | 15 M | 15 M | 15 M | 15 M | 7.17 M | 7.17 M | 7.17 M | 7.17 M | 3.14 M | 3.14 M | 3.14 M | 3.14 M | 8.44 M | 8.45 M | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | 108 K | 470 K | 552 K | 679 K | 686 K | 686 K | 686 K | 686 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 108 K | - | - | 13 K | 51 K | 248 K | 317 K | 317 K | 317 K | 317 K | 277 K | 277 K | 277 K | 277 K |
Retained Earnings |
- | -259 M | -254 M | -248 M | -242 M | -236 M | -230 M | -226 M | -220 M | -220 M | -220 M | -220 M | -198 M | -198 M | -198 M | -198 M | -155 M | -155 M | -155 M | -155 M | -106 M | -106 M | -106 M | -106 M | -68.6 M | -68.6 M | -68.6 M | -68.6 M | -48.5 M | -48.5 M | -48.5 M | -48.5 M | -36.1 M | -36.1 M | -36.1 M | -36.1 M | -29.9 M | 29.9 M | -104 M | -104 M | -107 M | -107 M | -107 M | -107 M | -98.7 M | -98.7 M | -98.7 M | -98.7 M |
Total Assets |
- | 12.2 M | 15.5 M | 20.7 M | 25.9 M | 30.4 M | 34 M | 37.7 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 27 M | 27 M | 27 M | 27 M | 46.8 M | 46.8 M | 46.8 M | 46.8 M | 36.1 M | 36.1 M | 36.1 M | 36.1 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 1.14 M | 1.14 M | 1.56 M | 1.56 M | 1.09 M | 1.09 M | 1.09 M | 1.09 M | 3.55 M | 3.55 M | 3.55 M | 3.55 M |
Cash and Cash Equivalents |
- | 5.91 M | 9.43 M | 14 M | 19.2 M | 22.7 M | 25.4 M | 28.4 M | 6.52 M | 6.52 M | 6.52 M | 6.52 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M | 29.5 M | 29.5 M | 29.5 M | 29.5 M | 20.7 M | 20.7 M | 20.7 M | 20.7 M | 8.09 M | 8.09 M | 8.09 M | 8.09 M | 7.36 M | 7.36 M | 7.36 M | 7.36 M | 895 K | 895 K | 895 K | 895 K | 430 K | 430 K | 769 K | 769 K | 449 K | 258 K | 258 K | 258 K | 2.58 M | 2.58 M | 2.58 M | 2.58 M |
Book Value |
- | 1.18 M | 5.28 M | 10.2 M | 15.1 M | 20.4 M | 25.1 M | 27.5 M | 6.97 M | 6.97 M | 6.97 M | 6.97 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 4.91 M | 4.91 M | 4.91 M | 4.91 M | -2.6 M | -2.6 M | -2.6 M | -2.6 M | -405 K | -405 K | -405 K | -405 K | 3.94 M | 3.94 M | 3.94 M | 3.94 M | -841 K | -841 K | -841 K | -841 K | -7.31 M | -7.31 M | 1.56 M | 1.56 M | 1.09 M | 1.09 M | 1.09 M | 1.09 M | 3.55 M | 3.55 M | 3.55 M | 3.55 M |
Total Shareholders Equity |
- | 1.18 M | 5.28 M | 10.2 M | 15.1 M | 20.4 M | 25.1 M | 27.5 M | 6.97 M | 6.97 M | 6.97 M | 6.97 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 4.91 M | 4.91 M | 4.91 M | 4.91 M | -2.6 M | -2.6 M | -2.6 M | -2.6 M | -405 K | -405 K | -405 K | -405 K | 3.94 M | 3.94 M | 3.94 M | 3.94 M | -841 K | -841 K | -841 K | -841 K | -7.31 M | -7.31 M | -6.64 M | -6.64 M | -3.08 M | -11.9 M | -11.9 M | -11.9 M | -4.09 M | -4.09 M | -4.09 M | -4.09 M |
All numbers in USD currency